Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different ...

Daiichi Sankyo is stepping up its interest in RNA therapies, teaming with Nosis Biosciences to design drug candidates capable ...

Japan-based Ono Pharmaceuticals has secured the global rights to sapablursen, an RNA-targeting therapy developed by Ionis ...

Researchers at Case Western Reserve University have discovered molecules that present the potential to drive the development of gastric cancer-among the world's deadliest forms of the disease.

Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) released topline results from Part 2 of a Phase 1/2 study of ARO-C3, the ...

Avidity Biosciences, Inc. (NASDAQ:RNA) has emerged as a frontrunner in ... Del-zota: Designed for DMD exon 44 skipping, this therapy has generated considerable excitement and could potentially ...

A new review article highlights the transformative role of circular RNA (circRNA) in cancer, revealing its potential as both a key player in tumor biology and a promising avenue for future therapies.

With further testing, discovery may offer new target for early detection and treatmentResearchers at Case Western Reserve ...

Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA ...

Voyager Therapeutics’ progress with drug candidates targeting tau marks a step in how the industry is walking multiple paths toward new therapeutic options.

Researchers developed pig retinal organoids similar to human ones, advancing stem cell-based vision restoration and enabling ...